LL-37
Human cathelicidin antimicrobial peptide (hCAP-18 C-terminal fragment LL-37); studied for antimicrobial and immunomodulatory activity.
Technical Dossier
Batch / Lot Number
—
Testing Status
—
Testing Laboratory
—
Test Date
—
Classification
Human cathelicidin antimicrobial peptide (hCAP-18 C-terminal fragment, LL-37)
Mechanism / Biological Target
Research Areas
Research Overview
Laboratory Storage & Handling
References
- The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
Review, 2021.
- Significance of LL-37 on Immunomodulation and Disease Outcome
Yang B, et al. Biomed Res Int, 2020.
- Antimicrobial host defence peptides: Functions and clinical potential (review)
Mookherjee N, et al. Nat Rev Drug Discov, 2020.
Available Documentation
- Certificate of AnalysisPending / Not yet available
For Research Use Only
Compounds referenced on Peptide Underground are intended for laboratory and research purposes only. They are not intended to diagnose, treat, cure, or prevent any disease and are not intended for human consumption.